Personal tools

Coexpression cluster:C3701: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C3701_iPS_oral_HES3GFP_Alveolar_leiomyoblastoma_rhabdomyosarcoma_testicular |id=C3701 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C3701_iPS_oral_HES3GFP_Alveolar_leiomyoblastoma_rhabdomyosarcoma_testicular
|full_id=C3701_iPS_oral_HES3GFP_Alveolar_leiomyoblastoma_rhabdomyosarcoma_testicular
|id=C3701
|id=C3701
|ontology_enrichment_celltype=CL:0000066!4.60e-28!254;CL:0002321!1.51e-18!248;CL:0000220!1.14e-17!246;CL:0002076!8.54e-11!43;CL:0000221!3.85e-09!71;CL:0000223!2.14e-08!59;CL:0000548!4.08e-08!679;CL:0000004!4.08e-08!679;CL:0000255!4.08e-08!679;CL:0000012!4.95e-08!682;CL:0002368!2.98e-07!13
|ontology_enrichment_disease=DOID:305!2.80e-08!106;DOID:0050687!8.52e-08!143
|ontology_enrichment_uberon=UBERON:0006554!6.33e-11!44;UBERON:0001008!2.97e-10!45;UBERON:0005177!3.32e-10!107;UBERON:0002113!2.08e-09!27;UBERON:0003918!2.08e-09!27;UBERON:0005095!2.08e-09!27;UBERON:0007687!2.08e-09!27;UBERON:0000119!4.56e-09!312;UBERON:0000483!1.07e-08!309;UBERON:0003104!1.11e-08!238;UBERON:0009142!1.11e-08!238;UBERON:0000464!2.70e-08!104;UBERON:0000489!5.11e-08!32;UBERON:0000466!6.81e-08!126;UBERON:0002100!8.76e-08!216;UBERON:0009569!2.16e-07!113;UBERON:0000481!3.49e-07!347;UBERON:0005085!3.69e-07!29;UBERON:0000080!6.77e-07!18;UBERON:0002120!6.77e-07!18;UBERON:0004875!6.77e-07!18;UBERON:0005721!6.77e-07!18;UBERON:0005754!6.77e-07!18;UBERON:0007297!6.77e-07!18
}}
}}

Revision as of 14:39, 21 May 2012


Full id: C3701_iPS_oral_HES3GFP_Alveolar_leiomyoblastoma_rhabdomyosarcoma_testicular



Phase1 CAGE Peaks

Hg19::chr17:79989976..79990030,+p@chr17:79989976..79990030
+
Hg19::chr17:79990035..79990049,+p@chr17:79990035..79990049
+
Hg19::chr17:79990058..79990075,+p@chr17:79990058..79990075
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell4.60e-28254
embryonic cell1.51e-18248
endo-epithelial cell8.54e-1143
ectodermal cell3.85e-0971
endodermal cell2.14e-0859
animal cell4.08e-08679
eukaryotic cell4.08e-08679
respiratory epithelial cell2.98e-0713
Uber Anatomy
Ontology termp-valuen
urinary system structure6.33e-1144
renal system2.97e-1045
trunk region element3.32e-10107
kidney2.08e-0927
kidney mesenchyme2.08e-0927
kidney rudiment2.08e-0927
kidney field2.08e-0927
cell layer4.56e-09312
epithelium1.07e-08309
mesenchyme1.11e-08238
entire embryonic mesenchyme1.11e-08238
anatomical space2.70e-08104
cavitated compound organ5.11e-0832
immaterial anatomical entity6.81e-08126
trunk8.76e-08216
subdivision of trunk2.16e-07113
multi-tissue structure3.49e-07347
ectodermal placode3.69e-0729
mesonephros6.77e-0718
pronephros6.77e-0718
nephrogenic cord6.77e-0718
pronephric mesoderm6.77e-0718
rostral part of nephrogenic cord6.77e-0718
presumptive pronephric mesoderm6.77e-0718
Disease
Ontology termp-valuen
carcinoma2.80e-08106
cell type cancer8.52e-08143


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.